Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Temasek-backed ABC Impact raises $600m to scale Asia-focused healthcare and climate investments
Temasek-backed ABC Impact raises $600m to scale Asia-focused healthcare and climate investments ABC Impact, the Temasek-backed private equity firm, has raised over $600m in its latest funding round to expand its impact investment strategy across Asia. The...
Morgan Stanley closes $2.3bn PECO III co-investment fund at hard cap to expand lower mid-market strategy
Morgan Stanley closes $2.3bn PECO III co-investment fund at hard cap to expand lower mid-market strategy Morgan Stanley Investment Management has reached the $2.3bn hard cap for its third co-investment fund, North Haven Private Equity Co-Investment Opportunities Fund...
EQT eyes minority stake in Musinsa as fashion platform eyes IPO on back of $1bn+ revenue milestone
EQT eyes minority stake in Musinsa as fashion platform eyes IPO on back of $1bn+ revenue milestone EQT Partners is in final-stage talks to acquire a minority stake in South Korean fashion platform Musinsa, in a secondary transaction valued at approximately KRW 20bn...